Exclusive - Syrian Democratic Forces Chief: We are Ready to Cooperate with Arab Forces

Syrian Democratic Forces (SDF) fighters ride on vehicles in the north of Raqqa city, Syria. (Reuters)
Syrian Democratic Forces (SDF) fighters ride on vehicles in the north of Raqqa city, Syria. (Reuters)
TT

Exclusive - Syrian Democratic Forces Chief: We are Ready to Cooperate with Arab Forces

Syrian Democratic Forces (SDF) fighters ride on vehicles in the north of Raqqa city, Syria. (Reuters)
Syrian Democratic Forces (SDF) fighters ride on vehicles in the north of Raqqa city, Syria. (Reuters)

Mazloum Abdi is the commander-in-chief of the Syrian Democratic Forces. Originally from the town of Ain al-Arab (Kobane) in northern Syria, he leads a force of 60,000 troops and recently held a lengthy meeting with Brett McGurk, the US Special Presidential Envoy for the Global Coalition to Defeat ISIS.

Abdi said the meeting discussed President Donald Trump’s intention to withdraw the US troops from Syria and the SDF’s willingness to cooperate with Arab countries that might send troops to fight within the Coalition, in case the US withdrew.

In an interview with Asharq Al-Awsat, Abdi said: “Officially, there is no decision to withdraw the US troops from Syria, but President Trump proposed the matter to members of his government for discussion. We have information that the administration is discussing his proposal and the possibility of withdrawing troops or not.”

“The US and the Coalition countries came to Syria to fight ISIS. The latter has not been eliminated completely, and there are sleeping cells in the liberated areas that continue to constitute a threat. There also remain pledges made by the US and the Coalition to the liberated areas and cities to rebuild and promote peace and stability,” the commander stated.

Asked about the possibility of deploying other forces in case of US withdrawal, Abdi replied: “There is nothing official to date, but countries have shown initial approval for sending their forces to Syria as part of the international coalition.”

“We are working with the Coalition to expel terrorism from Syria. We have no problem if Arab forces joined the alliance and we will cooperate with them,” he stressed.

The SDF commander noted that since the end of 2014 and the announcement of the anti-ISIS coalition, he had held several meetings with the US side, which pledged to provide military and financial support to enable local governments in northern Syria to expel ISIS and successfully manage these areas.

As for his relation with McGurk, Abdi said: “Brett McGurk is the US president’s representative in the Coalition and a friend of the Kurdish people. He had expressed this in many meetings.”

He added that a few days ago, the two men held a long meeting and discussed the withdrawal of US forces from east of the Euphrates River.

“I understood from him that the proposal is in the decision-making and drafting stage. It is important for us that the United States and the Coalition countries implement their commitments to the forces that have fought and are still fighting ISIS. These commitments are promises they have made to the public,” he emphasized.

Asked whether France was able to assume the American role in northern Syria, Abdi noted that the United States was the main force in the Coalition.

“But I do not think the size of the French military presence is comparable to that of the US,” he continued.

“[French] President [Emmanuel] Macron expressed his desire to expand the participation of his country’s forces in the Coalition and Britain showed a similar desire. These two countries contributed significantly to the war against ISIS,” he added.

As for the areas controlled by ISIS on the northern bank of the Euphrates, Abdi said: “ISIS elements currently control an area of about 10,000 square kilometers, which is equivalent to the area of Lebanon; stretching from the south of Al-Hol and Dasheheh in the province of Hasakeh, to the Euphrates along the Syrian-Iraqi border. They still constitute a danger.”

When asked why he believed ISIS has not been defeated yet in those areas, he replied: “Turkey is involved with ISIS, whose elements are engaged in proxy wars to implement Turkish agendas in Syria.”

“When Turkey threatens to invade Manbij and the Kurdish areas under the control of our forces, it will execute these threats through ISIS terrorists,” he stated.



Hevolution CEO Discusses Career in Innovation, Medicine, and Business

Dr. Mehmood Khan, CEO of the Hevolution Foundation
Dr. Mehmood Khan, CEO of the Hevolution Foundation
TT

Hevolution CEO Discusses Career in Innovation, Medicine, and Business

Dr. Mehmood Khan, CEO of the Hevolution Foundation
Dr. Mehmood Khan, CEO of the Hevolution Foundation

Dr. Mehmood Khan, CEO of the Hevolution Foundation, the largest philanthropy organization funding aging medicine in the world, expressed that receiving Saudi citizenship will boost his scientific and practical capabilities.
He said this new status will help him advance his research, especially in addressing aging.
This comes as part of a recent royal decree granting Saudi citizenship to several notable scholars, doctors, researchers, and innovators.
“Our Chairman, his Royal Highness (Crown Prince Mohammed bin Salman), has very high expectations of our work and the impact we need to do; We were created in part because of his vision,” Khan told Asharq Al-Awsat.
“Living up to the expectations and challenges we get faced with is itself exciting, but it is challenging,” revealed Khan, affirming that Hevolution’s team is “up to that task.”
Khan, who has experience in both corporate and medical fields, told Asharq Al-Awsat that his work across academic, public, and private sectors has been a continuous learning process, with each area enhancing the others.
According to the CEO, these industries are interconnected, and combining their strengths often leads to the best solutions.
This insight inspired the Hevolution initiative, which brings together the scientific community, NGOs, pharmaceutical companies, policymakers, academia, biotech firms, CEOs, and others to promote healthy aging.
Khan highlighted the value of integrating insights from different sectors.
Academia provides detailed research, the public sector offers insights on population health and regulations, and the corporate world brings innovation and efficiency, explained Khan, adding that by merging these perspectives, the world can tackle complex health challenges more effectively.
“We’ve been working through, and are now investing, funding and partnering with over 200 scientists around the world, and over 150 different university labs,” said Khan.
Hevolution uses this integrated approach to advance healthy aging.
This initiative embodies my passion for addressing major challenges and offers a significant opportunity to make a global impact.
Khan talked about the first $400 million commitment Hevolution made in the last 23 months, calling it “unprecedented.”
“There has never been a non-profit organization in the world that has gone from not existing to now becoming the largest philanthropy funding aging biology and medicine in the world,” affirmed Khan.
Khan stressed that work at Hevolution not only pushes scientific boundaries but also promotes cross-sector collaboration to improve global health outcomes.
Since Khan’s early days in medical school, he’s been deeply interested in nutrition and population health, which was an unconventional focus back then. This journey set the foundation for his later work in community health.
Khan’s time as an endocrinology faculty member at the Mayo Clinic was crucial. He led programs on diabetes, endocrine diseases, metabolism, and nutrition, which strengthened his expertise in designing disease prevention systems.
In the private sector, Khan took on a key role at Takeda Pharmaceutical as the global head of R&D, which shaped his approach to innovative healthcare solutions.
At PepsiCo, as Chief Scientific Officer, he learned crucial principles of scale, impact, transformation, and tackling global challenges.
As CEO of Hevolution, Khan uses all his professional experience to advance the foundation’s mission of developing health sciences to address age-related diseases.
Khan serves on the boards of Reckitt Benckiser and the Saudi Research, Development, and Innovation Authority (RDIA).
He is the CEO of Life Biosciences, a member of Saudi Arabia’s biotechnology strategy committee, and the chair of the advanced technology visiting committee at the US National Institute of Standards and Technology (NIST).
Khan told Asharq Al-Awsat that he feels honored to have recently become a Saudi citizen by royal decree, while also holding dual US and UK citizenship. This helps him lead Hevolution effectively and work closely with international partners.
Khan commented on his recent Saudi citizenship, saying that in addition to feeling honored to receive Saudi citizenship by royal decree, alongside other distinguished individuals, this recognition is a great privilege.
Being a Saudi citizen, as per Khan, is a significant milestone and acknowledges the progress in his work in aging science and global health. It also strengthens Khan’s commitment to the work at Hevolution.
Khan noted that this new status enhances his ability to build relationships and collaborate within the Kingdom and internationally. It offers a deeper connection with the local community and better opportunities to engage with policymakers and leaders.
He also said that this recognition boosts Hevolution’s global presence and credibility, making the foundation’s collaborations with international scientists and business leaders stronger. It positions Hevolution as a key player in addressing age-related diseases.
Khan emphasized that this honor reflects the hard work and innovation of Hevolution’s entire team.
The CEO said that it was collective efforts that have made this achievement possible.
Khan also said he is excited to engage more deeply with the scientific and medical community in the Kingdom, adding that his new citizenship helps him contribute to Vision 2030 and the national biotechnology strategy, promoting innovation and attracting top global talent.